Showing results (591-600 of 632) with videos related to

Sort By:
Pageof 64
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 29, 2024
Possible scenarios for the spread of mpox outside the endemic focus in AfricaEskild Petersen, Ulrik Hvid, Oyewale Tomori, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 4, 2021
Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort studyPeter Kamstrup, Pradeesh Sivapalan, Josefin Eklöf, et al.
AIDS (London, England)|February 10, 2018
No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell countsEdwina J Wright, Birgit Grund, Kevin R Robertson, et al.
The Lancet. HIV|February 9, 2020
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelinesAndrew N Phillips, Loveleen Bansi-Matharu, Francois Venter, et al.
Critical Care Medicine|May 17, 2011
Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trialJens U Jensen, Lars Hein, Bettina Lundgren, et al.
Medicine|July 20, 2018
Classification of death causes after transplantation (CLASS): Evaluation of methodology and initial resultsNeval Ete Wareham, Caspar Da Cunha-Bang, Álvaro H Borges, et al.
The Lancet. HIV|November 28, 2017
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling studyAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
Critical Care Medicine|December 11, 2014
Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroximeJens-Ulrik S Jensen, Lars Hein, Bettina Lundgren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2025
Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohortWin Min Han, Lene Ryom, Caroline A Sabin, et al.
The Lancet. Infectious Diseases|March 1, 2011
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort studyLinda Wittkop, Huldrych F Günthard, Frank de Wolf, et al.
Pageof 64